The race to apply AI to medical treatment is rapidly accelerating in China and Japan.
Breast cancer is on the rise across Asia, with more women contracting the disease than ever before.
MRI-compatible pacemakers are among the technologies gaining traction.
Many considerations should not be overlooked.
The country is trying to supplant the United States as the world leader in this sector.
The need is growing for life-saving treatments.
The president’s tariffs on imports, especially steel and aluminum, could increase input production costs, making products more expensive.
It’s critical to understand the characteristics of this country’s market to determine the most effective steps.
Although the market is expected to experience strong growth, the quality of care is inconsistent.
Economic development in China has created a burgeoning middle class that demands higher standards of living.